KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2025)

Amneal Pharmaceuticals has reported Exchange Rate Effect over the past 9 years, most recently at -$209000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$209000.0 for Q4 2025, up 71.76% from a year ago — trailing twelve months through Dec 2025 was -$1.7 million (down 68.17% YoY), and the annual figure for FY2025 was -$1.7 million, down 68.17%.
  • Exchange Rate Effect for Q4 2025 was -$209000.0 at Amneal Pharmaceuticals, up from -$694000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for AMRX hit a ceiling of $767000.0 in Q1 2023 and a floor of -$3.7 million in Q4 2022.
  • Median Exchange Rate Effect over the past 5 years was -$255000.0 (2023), compared with a mean of -$409750.0.
  • Biggest five-year swings in Exchange Rate Effect: skyrocketed 148.79% in 2023 and later plummeted 10014.29% in 2025.
  • Amneal Pharmaceuticals' Exchange Rate Effect stood at $178000.0 in 2021, then crashed by 2200.56% to -$3.7 million in 2022, then surged by 105.38% to $201000.0 in 2023, then crashed by 468.16% to -$740000.0 in 2024, then skyrocketed by 71.76% to -$209000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$209000.0 (Q4 2025), -$694000.0 (Q3 2025), and -$307000.0 (Q2 2025) per Business Quant data.